One of the adjuncts in the treatment and prognostication of breast cancer patients is the determination of hormone status, such as estrogen (ER) and progesterone receptors (PR), and human epidermal receptor 2 (HER2) receptors. The gene discussed is PGR; the disease is breast carcinoma.